Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia; this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts.

Citations

Citations to this article as recorded by  

• Assessing Inflammatory Bowel Disease Care Quality in Portugal: A Nationwide Gastroenterologist Survey
  Paula Ministro, Diana Carvalho, Luís Correia, Cláudia Camila Dias, Raquel Gonçalves, Paula Lago, Fernando Magro, Sandra Dias, Francisco Portela
  GE - Portuguese Journal of Gastroenterology.2026; : 1.     CrossRef
• Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review
  Simone Chin, Kathryn Demase, Crispin Corte, Darren Wong, Ralley Prentice, Peter De Cruz
  Inflammatory Bowel Diseases.2026;[Epub]     CrossRef
• Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis
  Norah Karlovich, Ryan McConnell, Fernando Velayos, Uma Mahadevan, Sara Lewin
  Inflammatory Bowel Diseases.2025; 31(5): 1197.     CrossRef
• Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease
  Liselotte Fierens, Peter Bossuyt, Filip Baert, Didier Baert, Caroline Weltens, Marga Lavaerts, Kris Vanhaecht, Frank E. Rademakers, Marc Ferrante
  European Journal of Gastroenterology & Hepatology.2024; 36(9): 1075.     CrossRef
• Framework of IBD Care Delivery Across Ages
  Stefan Delen, Susanna Jaghult, Irina Blumenstein, Lieven Pouillon, Peter Bossuyt
  Journal of Crohn's and Colitis.2024; 18(Supplement): ii55.     CrossRef
• Clinical outcomes amongst elderly patients with inflammatory bowel disease
  Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson‐O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J. V. Thompson, Michael A. Kamm
  Internal Medicine Journal.2023; 53(10): 1866.     CrossRef
• Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease
  Chung Sang Tse, Aricca D Van Citters, Brittany Ricci, Noah Z Freundlich, Moses Lee, Samir A Shah, Gil Y Melmed, Corey A Siegel, Welmoed K van Deen, Christopher Almario, Rose Arrieta, Andrea Banty, Harry Bray, Catherine Bresee, Jessica Carron, Aline Charab
  Journal of Crohn's and Colitis.2022; 16(3): 379.     CrossRef
• Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review
  David I. Fudman, Andrea Escala Perez-Reyes, Blake A. Niccum, Gil Y. Melmed, Hamed Khalili
  Clinical Gastroenterology and Hepatology.2022; 20(9): 1947.     CrossRef
• Consenso latinoamericano acerca de indicadores de calidad para Clínicas de Atención Integral para pacientes con enfermedad inflamatoria intestinal: PANCCO-GETECCU
  J.K. Yamamoto-Furusho, D. Andrade, J. Barahona, S. Bautista, F. Bosques-Padilla, J. de Paula, M.T. Galiano, B. Iade, F. Juliao-Baños, G. Otoya, F. Steinwurz, E. Torres, G. Veitia, M. Barreiro-de Acosta
  Revista de Gastroenterología de México.2022; 87(1): 89.     CrossRef
• Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU
  J.K. Yamamoto-Furusho, D. Andrade, J. Barahona, S. Bautista, F. Bosques-Padilla, J. de Paula, M.T. Galiano, B. Iade, F. Juliao-Baños, G. Otoya, F. Steinwurz, E. Torres, G. Veitia, M. Barreiro-de Acosta
  Revista de Gastroenterología de México (English Edition).2022; 87(1): 89.     CrossRef
• Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease
  Jeremy Adler, Sally J Eder, Acham Gebremariam, Christopher J Moran, Lee M Bass, Jonathan Moses, Jeffery D Lewis, Andrew A M Singer, Tina L Morhardt, Joseph A Picoraro, Vanessa Cardenas, George M Zacur, Richard B Colletti
  Inflammatory Bowel Diseases.2022; 28(10): 1537.     CrossRef
• A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease
  Robert Battat, Jonathan S. Galati, Dana Lukin, Fatiha Chabouni, Robbyn Sockolow, Jeff Carter, Kristina Fajardo, Stevie Yang, Jenna Reich, Vinita Jacobs, Meira Abramowitz, Anand Kumar, Paul Christos, Randy S. Longman, Robert Burakoff, Laura Simone, Tamar S
  Journal of Clinical Gastroenterology.2022; 56(3): e176.     CrossRef
• Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center
  Shen Jun, Liang Jie, Mao Ren, Ran Zhihua
  Inflammatory Bowel Diseases.2022; 28(Supplement): S3.     CrossRef
• Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease
  Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel R. Van Langenberg
  Diagnostics.2022; 12(10): 2533.     CrossRef
• Are Quality Metrics in Inflammatory Bowel Disease Rooted in Substantial Quality Evidence? A Systematic Review
  Simcha Weissman, Alexander Goldowsky, Tej I Mehta, Michael A Sciarra, Joseph D Feuerstein
  Journal of Crohn's and Colitis.2021; 15(2): 326.     CrossRef
• Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes
  Simon J. Hong, Janice Jang, Dana Berg, Tarik Kirat, Feza Remzi, Shannon Chang, Lisa B. Malter, Jordan E. Axelrad, David P. Hudesman
  Digestive Diseases and Sciences.2021; 66(11): 3753.     CrossRef
• Identifying and Predicting the Goals and Concerns of Individuals with Inflammatory Bowel Disease
  Chung Sang Tse, Aricca D. Van Citters, Brittany Ricci, Noah Z. Freundlich, Moses Lee, Samir A. Shah, Gil Y. Melmed, Corey A. Siegel, Welmoed K. van Deen
  SSRN Electronic Journal .2021;[Epub]     CrossRef
• Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology
  Yong Eun Park, Jin Lee, Jongha Park, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Yoon Kyoung Lee, Tae Oh Kim
  The Korean Journal of Gastroenterology.2021; 78(1): 37.     CrossRef
• The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care
  Jonathan A. Beard, Diana L. Franco, Benjamin H. Click
  Current Gastroenterology Reports.2020;[Epub]     CrossRef
• Opioid Use in Patients With Inflammatory Bowel Disease
  Xiwu Lin, Jennifer Lofland, Ling Zhang, Sheldon Sloan, Laila Chamaa, Colleen Marano, Scott Plevy
  Crohn's & Colitis 360.2020;[Epub]     CrossRef
• The burden of cost in inflammatory bowel disease: a medical economic perspective
  Jonathan A. Beard, Benjamin H. Click
  Current Opinion in Gastroenterology.2020; 36(4): 310.     CrossRef

• New Zealand National Audit of Outpatient Inflammatory Bowel Disease Standards of Care

  
  Robert Hackett, Richard Gearry, Christine Ho, Andrew McCombie, Megan Mackay, Karen Murdoch, Kirsten Rosser, Nideen Visesio, Stephen Inns
  Clinical and Experimental Gastroenterology.2020; Volume 13: 285.     CrossRef
• Improving the quality of care for inflammatory bowel disease
  Byong Duk Ye, Simon Travis
  Intestinal Research.2019; 17(1): 45.     CrossRef
• Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
  Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
  Journal of Gastroenterology and Hepatology.2019; 34(7): 1166.     CrossRef
• The Inflammatory Bowel Disease Medical Home: From Patients to Populations
  Benjamin Click, Miguel Regueiro
  Inflammatory Bowel Diseases.2019; 25(12): 1881.     CrossRef
• Medication non-adherence in inflammatory bowel diseases is associated with disability
  Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
  Intestinal Research.2018; 16(4): 571.     CrossRef
• Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
  Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
  World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef